These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17088225)

  • 1. Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?
    Feeney GF; Connor JP; McD Young R; Tucker J; McPherson A
    J Addict Dis; 2006; 25(4):49-58. PubMed ID: 17088225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2004 Oct; 38(10):842-8. PubMed ID: 15369544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
    Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
    Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
    Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
    Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
    Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
    J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being.
    Laaksonen E; Vuoristo-Myllys S; Koski-Jannes A; Alho H
    Alcohol Alcohol; 2013; 48(6):687-93. PubMed ID: 23813295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
    Poldrugo F
    Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
    Lejoyeux M; Lehert P
    Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
    Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
    Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate and primitive reflexes.
    Guzik P; Bankes L; Brown TM
    Ann Pharmacother; 2007 Apr; 41(4):715-8. PubMed ID: 17389668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support.
    Morgan MY; Landron F; Lehert P;
    Alcohol Clin Exp Res; 2004 Jan; 28(1):64-77. PubMed ID: 14745303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate for alcohol dependence?
    Drug Ther Bull; 1997 Sep; 35(9):70-2. PubMed ID: 9350085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.